Nick is a third-year PhD student in Duke University’s Pathobiology and Translational Biosciences program, where he is also completing a concurrent master’s in Biomedical Engineering. His research focuses on elucidating biochemical mechanisms underlying the development of osteoarthritis, emphasizing clinical applications in tissue engineering and additive manufacturing to create novel therapeutic strategies that improve patient outcomes. Upon graduation, he aims to partner with medical professionals and capital investors to translate innovative ideas into new MedTech ventures and commercialize impactful healthcare solutions.